Aytu BioPharma, Inc.AYTUNASDAQ
Loading
Year-over-year total asset growth rate
Percentile
P51
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -2.39% |
| Q3 2025 | 0.65% |
| Q2 2025 | -0.02% |
| Q1 2025 | 6.86% |
| Q4 2024 | 0.34% |
| Q3 2024 | -2.55% |
| Q2 2024 | -7.76% |
| Q1 2024 | -1.82% |
| Q4 2023 | -1.23% |
| Q3 2023 | -3.59% |
| Q2 2023 | -6.37% |
| Q1 2023 | 4.09% |
| Q4 2022 | -5.71% |
| Q3 2022 | 8.99% |
| Q2 2022 | -18.48% |
| Q1 2022 | -24.57% |
| Q4 2021 | -1.71% |
| Q3 2021 | -14.28% |
| Q2 2021 | -2.17% |
| Q1 2021 | 62.86% |
| Q4 2020 | 18.03% |
| Q3 2020 | -7.84% |
| Q2 2020 | -3.56% |
| Q1 2020 | 113.42% |
| Q4 2019 | 140.06% |
| Q3 2019 | -10.65% |
| Q2 2019 | -9.43% |
| Q1 2019 | -9.58% |
| Q4 2018 | 135.75% |
| Q3 2018 | -14.60% |
| Q2 2018 | -9.90% |
| Q1 2018 | 23.95% |
| Q4 2017 | -11.24% |
| Q3 2017 | 41.65% |
| Q2 2017 | -5.77% |
| Q1 2017 | -25.99% |
| Q4 2016 | 6.46% |
| Q3 2016 | -17.02% |
| Q2 2016 | 10.72% |
| Q1 2016 | -9.93% |